|Day Low/High||0.00 / 0.00|
|52 Wk Low/High||42.31 / 64.60|
Jim Cramer focuses on Merck, Eli Lilly, Abbott Labs, Phillips 66, Five Below, and Cintas in the Lightning Round.
Do we trade on the news out of Washington? Jim Cramer talks about Larry Kudlow and his stand on economic growth.
Jim Cramer highlights Corning, Freeport-McMoran, McDonald's, Ventas, Kindred Healthcare.
Jim Cramer says if investors want to stick with what's working, then they definitely need to be in tech.
We continue to view Abbott as our favorite healthcare play.
-- HEARTMATE 3™ LVAD DEMONSTRATED IMPROVED CLINICAL OUTCOMES OVER THE MOST WIDELY USED LVAD IN THE WORLD
TheStreet's founder Jim Cramer and a panel of top experts discuss how investors should be positioning their portfolio for March in this month's Trading Strategies session. In this clip above, listen to them discuss healthcare stocks and why they think they're too hard to trade.
- First and only pediatric mechanical heart valve developed to include newborns and infants
Senator Tina Smith wants some answers from a group of Big Pharma companies about how the new cash flowing from the corporate tax break will be spent.
Jim Cramer takes a look at Square, Manitowoc, Valley National Bancorp, FMC Corp., Universal Display, CIT Group, Oneok, and Albemarle.
Nobody likes tariffs, says Jim Cramer. But Trump said he'd do it. Even so, trade and tariff fears have hit Wall Street -- and investors -- hard.
Jim discusses Comcast's bid for Sky, Broadcom, Fed Chair Powell's testimony and more.
ABT has been in a strong and durable uptrend and that is likely to continue.
- COMPANIES TO COLLABORATE ON PRODUCT DEVELOPMENT, CLINICAL TRIALS AND REGULATORY ACTIVITIES TO OBTAIN APPROVAL IN U.S. AND E.U.
As quick as last week's selloff occurred, this rebound higher has been just as fast, and we would not be surprised to see the market retest at some point.
Rearranging the bullpen to add four names, including Amazon, and drop four others, including Amex.
Jim Cramer highlights Roku, Amazon, Teladoc, Weyerhaeuser, Mondelez International, Mazor Robotics, and Kratos Defense & Security.
Jim Cramer tackles the volatility issue and outlines the game plan for next week.
We are adding to our ABT position, as its stock is now getting absolutely no credit for a terrific Q4.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.